Morphine Sulfate Tablet, Film Coated, Extended Release
NDC Package 72162-1790-3
Package Information
Morphine Sulfate tablets is morphine sulfate extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.Limitations of UseBecause of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations[see Warnings and Precautions (5.1)], reserve morphine sulfate extended-release tabletsfor use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.Morphine sulfate extended-release tabletsare not indicated as an as-needed (prn) analgesic. This formulation utilizes a tablet, film coated, extended release delivery system. Marketed by Bryant Ranch Prepack, this product is identified by NDC 72162-1790 and is authorized under FDA application ANDA078761.
Identification & Billing
- RxCUI: 891888 - morphine sulfate 30 MG Extended Release Oral Tablet
- RxCUI: 891888 - MS 30 MG Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72162 - Bryant Ranch Prepack
- 72162-1790 - Morphine Sulfate
- 72162-1790-3 - 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
- 72162-1790 - Morphine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72162-1790). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72162-1790-3 identifies a specific commercial package of 30 tablet, film coated, extended release in 1 bottle of Morphine Sulfate, a human prescription drug labeled by Bryant Ranch Prepack. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet, film coated, extended release is formulated for oral use and contains morphine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bryant Ranch Prepack on May 11, 2012. The current certification is valid through December 31, 2026.
How is this Bryant Ranch Prepack product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72162179003. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.